pharma · Acute Myeloid Leukemia · Narcolepsy · JAZZ
Jazz Pharmaceuticals Ireland
Jazz Pharmaceuticals Ireland Limited
Jazz Pharmaceuticals Ireland is a pharma organization headquartered in Dublin, IE. It trades on NYSE under ticker JAZZ. Primary therapeutic focus areas include Acute Myeloid Leukemia, Narcolepsy, Epilepsy, Acute Lymphobl
Waterloo Exchange, Waterloo Road, Dublin, 4, IE HQ
2003 Founded
3,631 Employees
Public company Type
JAZZ · NYSE Ticker
Company details
- Status
- Public
- HQ
- Waterloo Exchange, Waterloo Road, Dublin, 4, IE
- Founded
- 2003
- Employees
- 3,631
- Programs
- 208
- Drugs
- 91
- Patents
- 89
Asparaginase Erwinia chrysanthemi
Phase 2 · small molecule · B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Asparaginase Erwinia chrysanthemi for B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative is a Phase 2 program (small_molecule) at Jazz Pharmaceuticals Ireland Limited with 1 ClinicalTrials.gov record(s).
Internal code RG1124788
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Jazz Pharmaceuticals Ireland Limited
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
- Status
- active
- Trials
- 1